Study on the Influence of Forest Therapy on Healing Experience in Botanical Gardens.
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Taipei City Hospital
- Enrollment
- 42
- Locations
- 2
- Primary Endpoint
- questionnaire: BPOMS (1st)
Study Overview
Brief Summary
The forest healing system is an important topic of alternative therapy in recent years. To study the influence of Forest therapy, the establishment of a pilot experimental model system in which both environmental factors and type of activity are necessary. Therefore, a system based on the Taipei Botanical Garden was introduced by this study.
Detailed Description
The forest healing system is an important topic of alternative therapy in recent years. Forest therapy began in 1989 when the psychology professor Kaplan put forward the "Attention Restoration Theory(ART)". Awareness has a positive benefit. To study the influence of Forest therapy, the establishment of a pilot experimental model system in which both environmental factors and type of activity are controlled can greatly reduce the errors caused by the site and the content of the activity. Therefore, a randomized controlled crossover experiment based on the Taipei Botanical Garden was introduced by this study.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Crossover
- Primary Purpose
- Health Services Research
- Masking
- None
Eligibility Criteria
- Ages
- 20 Years to 35 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •20-35 years old youth (not limited to men and women)
- •Those who have the ability and physical strength to walk for more than 120 minutes
- •Subjects must voluntarily join the study
Exclusion Criteria
- •People who smoke or chew betel nuts
- •People who have the habit of drinking (drinking more than five standard glasses in any situation)
- •Drug addiction (including narcotic drugs and non-narcotics) habitual
- •Those who have taken psychosomatic drugs in the past 30 days
- •Participating in another clinical trial at the same time, or in the follow-up period of an interventional trial
- •Those diagnosed with major injuries
- •Women who are currently pregnant or breastfeeding
- •Conditions where other subjects cannot cooperate (for example: unable to participate after random assignment, and not signing the subject's consent form)
Outcomes
Primary Outcomes
questionnaire: BPOMS (1st)
Time Frame: baseline, pre-intervention(1st) → 2 hours intervention → immediately after the intervention(1st)
Change from baseline Brief Profile of Mood States at first intervention
physiological indicator: HRV (Heart Rate Variability) (2nd)
Time Frame: pre-intervention(2nd) → 2 hours intervention → immediately after the intervention(2nd)
Change from HRV by using wrist monitors (ANSWatch®) to measure heart rate, heart rate variability (related to activities of the autonomic nervous system ANS), irregular heartbeats (IRRHB), and 5-minute continuous pulse wave at second intervention after 7-day-washout
questionnaire: BPOMS (2nd)
Time Frame: pre-intervention(2nd) → 2 hours intervention → immediately after the intervention(2nd)
Change from Brief Profile of Mood States at second intervention after 7-day-washout period \& cross-over
questionnaire: BDI-II (1st)
Time Frame: baseline, pre-intervention(1st) → 2 hours intervention → immediately after the intervention(1st)
Change from baseline The Beck Depression Inventory II at first intervention
questionnaire: BAI (1st)
Time Frame: baseline, pre-intervention(1st) → 2 hours intervention → immediately after the intervention(1st)
Change from baseline The Beck Anxiety Inventory at first intervention
questionnaire: BAI (2nd)
Time Frame: pre-intervention(2nd) → 2 hours intervention → immediately after the intervention(2nd)
Change from The Beck Anxiety Inventory at second intervention after 7-day-washout
questionnaire: BDI-II (2nd)
Time Frame: pre-intervention(2nd) → 2 hours intervention → immediately after the intervention(2nd)
Change from The Beck Depression Inventory II at second intervention after 7-day-washout
questionnaire: BSRS-V (1st)
Time Frame: baseline, pre-intervention(1st) → 2 hours intervention → immediately after the intervention(1st)
Change from baseline Brief Symptom Rating Scale V at first intervention
physiological indicator: alpha-amylase activity in salivary (1st)
Time Frame: baseline, pre-intervention(1st) → 2 hours intervention → immediately after the intervention(1st)
Change from baseline alpha-amylase activity in salivary by using commercial kits (Salimetrics®) at first intervention
physiological indicator: HRV (Heart Rate Variability) (1st)
Time Frame: baseline, pre-intervention(1st) → 2 hours intervention → immediately after the intervention(1st)
Change from baseline HRV by using wrist monitors (ANSWatch®) to measure heart rate, heart rate variability (related to activities of the autonomic nervous system ANS), irregular heartbeats (IRRHB), and 5-minute continuous pulse wave at first intervention
physiological indicator: blood pressures (systolic and diastolic) (1st)
Time Frame: baseline, pre-intervention(1st) → 2 hours intervention → immediately after the intervention(1st)
Change from baseline blood pressures by using wrist monitors (ANSWatch®) to measure blood pressures (systolic and diastolic) at first intervention
physiological indicator: blood pressures (systolic and diastolic) (2nd)
Time Frame: pre-intervention(2nd) → 2 hours intervention → immediately after the intervention(2nd)
Change from blood pressures by using wrist monitors (ANSWatch®) to measure blood pressures (systolic and diastolic) at second intervention after 7-day-washout
questionnaire: BSRS-V (2nd)
Time Frame: pre-intervention(2nd) → 2 hours intervention → immediately after the intervention(2nd)
Change from Brief Symptom Rating Scale V at second intervention after 7-day-washout
physiological indicator: alpha-amylase activity in salivary (2nd)
Time Frame: pre-intervention(2nd) → 2 hours intervention → immediately after the intervention(2nd)
Change from alpha-amylase activity in salivary by using commercial kits (Salimetrics®) at second intervention after 7-day-washout
Secondary Outcomes
No secondary outcomes reported
Investigators
Chung-Hua Hsu
Clinical Professor
Taipei City Hospital